Deepbridge has recently deployed an investment of £250,000 into Levitex Foams Limited, through the Deepbridge Life Sciences EIS fund. This follows on from an initial seed funding investment of £150,000, via the Deepbridge Life Sciences SEIS fund.
About Levitex Foams Ltd
Levitex Foams Ltd has developed a new foam product that aims to redistribute pressure and posture, with a particular focus on users that are bed-bound. Being bed-bound can potentially lead to pressure sores resulting in a worsening of the patient’s general health condition, which could lead to an extended and more costly stay in hospital.
- November 2022 (3)
- October 2022 (3)
- September 2022 (8)
- August 2022 (6)
- July 2022 (2)
- June 2022 (1)
- May 2022 (8)
- April 2022 (7)
- March 2022 (7)
- February 2022 (9)
- January 2022 (13)
- December 2021 (3)
- November 2021 (5)
- October 2021 (7)
- September 2021 (4)
- August 2021 (4)
- July 2021 (3)
- June 2021 (6)
